Published on: 21 June 2025
Category: Health News I Infectious Diseases & Outbreaks I
Fungal Infection
Written By:
Dewanshee Ingale, BPharm
Reviewed and Fact-Checked By:
Pharmacally Medical News Team
Aspergillus fumigatus, a silent but very deadly fungus, is rapidly spreading at a very alarming rate throughout the United States. Aspergillus fumigatus is a prevalent environmental fungus that is gradually being identified as a threat to public health. Initially, this organism was only known to affect the immune systems of immunocompromised patients. But now it has been clear that this fungus is expanding its reach; this fungus is airborne and spreads farther than it did in previous times. Its drug-resistant strain poses a threat to global infectious disease management. Experts in this field warn that not only the USA but also the world is not prepared for the threat that will be caused by the outbreak and spread of this fungus. As the infection rate climbs, especially in areas with warm, humid climates and also in urban, high-density populations, Aspergillus fumigatus poses serious complications to healthcare systems as well as endangers the vulnerable populations across the USA and globally in coming days.
Aspergillus Fumigatus
Aspergillus fumigatus is mold found in the environment at various places like soil, decaying leaves, and compost, and it is also found in indoor environments. The exposure is common to this fungus, and it presents little threat to healthy individuals; however, it can show serious complications in individuals with immunocompromised status or with chronic lung conditions.
The spores of the fungus Aspergillus fumigatus enter the body via the respiratory tract through the air we inhale. The spores reach the nose, throat, sinuses, and lungs. When these spores enter the body of healthy individuals, the immune system usually clears the spores. When these spores enter the bodies of people with compromised immunity or pre-existing lung diseases, the fungus invades the tissues, disrupts immune cell function, forms blood clots, and may also trigger severe allergic reactions.
Major Health Risks and Types of Aspergillosis
The infection with Aspergillus fumigatus can cause a range of conditions collectively known as aspergillosis in people with weakened immune systems or lung conditions. These include:
Allergic Bronchopulmonary Aspergillosis (ABPA): The allergic reaction produced as a reaction to the inhaled spores is most common in individuals with asthma, cystic fibrosis, or bronchiectasis. The symptoms observed are wheezing, coughing, shortness of breath, fever, and, many times, brown or bloody mucus. ABPA may worsen due to the presence of an underlying lung disease and can cause serious asthma attacks.
Chronic pulmonary aspergillosis (CPA) is a progressively growing infection mainly observed in patients with chronic lung diseases like tuberculosis or emphysema. The symptoms reported are persistent cough, severe weight loss, fatigue, breathlessness, and sometimes the occurrence of blood in the cough (hemoptysis), and they may often lead to notable lung damage and scarring if they are not treated.
Aspergilloma (“Fungus Ball”): The fungus forms a tangled mass inside the lung cavity. It often stays asymptomatic but can cause coughing up blood, which may turn severe.
Invasive Aspergillosis the most serious form, seen in the people with seriously weakened immune systems for example cancer, organ transplant, prolonged steroid use etc. the symptoms observed are fever, chest pain, cough (sometimes with blood), shortness of breath, and if the infection still persists may lead to neurological symptoms or often organ dysfunction. This particular form may be life-threatening and may require urgent medications.
Fungal Sinusitis and Other Forms: Spores often infect the sinuses, which cause a stuffy or runny nose, facial pain, headaches, and a decreased sense of smell. In some rare cases, the fungus may also spread through the eyes, skin, brain, or digestive tract, which may lead to the development of additional symptoms like red eyes, blurred vision, skin ulcers, confusion, and abdominal pain.
Who is at risk?
People suffering from cancer, HIV/AIDS, or organ transplants or under the therapy of immunosuppressive drugs have weak immunity, or individuals with chronic lung diseases such as asthma, cystic fibrosis, COPD, or tuberculosis and patients who have recently recovered from serious viral infections like influenza or COVID-19 are at major risk and require mechanical ventilation. Such people are exposed to environments that have a concentration of mold spores, for example, compost heaps, damp buildings, or construction sites.
Details of the U.S. Outbreak
As of mid-2025, multiple states in the U.S., including California, Texas, and New York, have reported a spike in invasive aspergillosis cases caused by azole-resistant Aspergillus fumigatus (ARAf). The Centers for Disease Control and Prevention (CDC) has confirmed that several isolates have genetic mutations associated with environmental fungicide exposure.
Why Is the Outbreak Getting Worse?
Several factors accelerate the spread and the impact of the Aspergillus fumigatus:
Climate Change: Overall, the increasing global warming has caused increased global temperatures and increased humidity that create an environment that is more favorable for the fungus to grow and spread, allowing the fungus to bloom in new areas and increase the risk to life.
Drug Resistance: The overuse of fungicide agents in the agricultural processes leads to the production of strains that are resistant to the first-line antifungal drugs, especially azole antifungals such as voriconazole or itraconazole, which makes the infection more difficult to treat and increases the complications associated with the fungus.
Population Vulnerability: The number of people with compromised immunity is continuously increasing due to the advancements in cancer treatments, organ transplantation, and other chronic disease management.
Environmental Disturbance: The increase in environmental disturbances like construction, renovations, and the occurrence of natural disasters leads to the release of large amounts of spores in the air, which further leads to a significant increase in the risk of outbreaks, especially in the healthcare systems.
USA’s Preparedness and Response
The United States faces significant challenges in tracking and fighting Aspergillus fumigatus-affected patients,, which makes it more difficult to control the outbursts and protect the susceptible populations
The CDC Mycotic Diseases Branch is actively monitoring for azole-resistant Aspergillus fumigatus (ARAf) and promoting molecular testing to detect resistance mutations like TR34/L98H and TR46/Y121F/T289A.
The CDC has promoted antifungal stewardship in healthcare settings to prevent unnecessary use of azole antifungals, parallel to antibiotic stewardship efforts.
Advisory alerts were issued to hospitals and clinicians in affected states (e.g., California, Texas, and New York) recommending
- Heightened awareness in transplant units and ICUs
- Use of molecular diagnostics for suspected resistant strains
- Review of fungicide usage data in surrounding agricultural areas
Recognizing that drug-resistant Aspergillus has environmental origins, U.S. agencies are advancing a One Health approach through the Environmental Protection Agency, which works on regulating fungicide use in agriculture to reduce environmental resistance pressures.
Global concerns
Fungal spores can travel long distances in the air. What starts as a localized outbreak can quickly become a global bio-risk; hence, the threat associated with Aspergillus fumigatus is not only confined to the USA but is also susceptible to global spread by expanding its range, exposing millions more people in Europe, Asia, and the Americas.
The rising number of people undergoing chemotherapy, organ transplants, or long-term corticosteroid therapy makes the global population increasingly vulnerable for infection.
How to Stay Safe from Aspergillus Fumigatus
These are the steps that one must ensure to reduce the risk of this fungus, especially if you are immunocompromised:
Avoid visiting dusty and moldy areas: Staying away from construction sites, renovation zones, compost piles, and places with visible mold would help prevent the spread of infection.
Use Protective Gear: Use protective gear like an N95 mask and gloves whenever you visit such places that pose risks.
Keep Indoor Air Clean: Using HEPA filters at home and inside the hospital rooms to reduce the entry of airborne spores.
Practice Good Hygiene: Wash your hands more often and at regular intervals, especially when you are outdoors, and also make sure to clean the cuts and wounds, if any.
Monitor Your Health: If you have weak immunity and you feel symptoms like a persistent cough, fever, or shortness of breath, immediately see a doctor and seek medical therapy.
Consult Your Doctor: People who are at high risk should communicate with their physicians about the extra preventive measures to be taken to stay safe from the fungal infection, including the antifungal therapies.
By staying informed and following these precautions, you can help protect yourself and your loved ones from this emerging fungal threat.
Conclusion
Aspergillus fumigatus is a blooming public health threat in the US and all around the globe. The rapid spread of this fungus, the increasing resistance to drugs, and the susceptibility of the increasing populations demand immediate consideration from the health organizations, various researchers, and policymakers. The use of protective measures is very crucial to minimize its impact and safeguard public health in the upcoming future.
Reference
Global pandemic warning: Aspergillus deadly fungus mirrors HBO’s ‘The Last of Us’, Times of India, https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/global-pandemic-warning-aspergillus-deadly-fungus-mirrors-hbos-the-last-of-us/articleshow/121438926.cms
Deadly fungus in US threatens lives as infection rates rise in these seven states, Hindustan Times, https://www.hindustantimes.com/world-news/deadly-aspergillus-fumigatus-in-us-threatens-lives-as-infection-rates-rise-in-these-seven-states-101750078523990.html
Aspergillus: All about the fungus that could spark a pandemic like in HBO’s ‘The Last of Us’, Economic Times, https://economictimes.com/news/international/global-trends/aspergillus-all-about-the-fungus-that-could-spark-a-pandemic-like-in-hbos-the-last-of-us/articleshow/121380695.cms
Hiel SJP, Hendriks ACA, Eijkenboom JJA, et al, Aspergillus Outbreak in an Intensive Care Unit: Source Analysis with Whole Genome Sequencing and Short Tandem Repeats. J Fungi (Basel). 2024 Jan 6; 10(1):51. doi: 10.3390/jof10010051. PMID: 38248960; PMCID: PMC10817286.
Data and Statistics on Aspergillosis, US centre for disease control and prevention, https://www.cdc.gov/aspergillosis/statistics/index.html
Risk Factors and Environmental Preventive Actions for Aspergillosis in Patients with Haematological Malignancies https://pmc.ncbi.nlm.nih.gov/articles/PMC10888107/
Arastehfar A, Carvalho A, Houbraken J,et al, Aspergillus fumigatus and aspergillosis: From basics to clinics. Stud Mycol. 2021 May 10;100:100115. Doi: 10.1016/j.simyco.2021.100115. PMID: 34035866; PMCID: PMC8131930.
Rising temperatures could spread deadly fungus, experts warn, and other health stories Global Heat Health Information Network, https://ghhin.org/news/rising-temperatures-could-spread-deadly-fungus-experts-warn-and-other-health-stories/
Aspergillosis Symptoms and Diagnosis, American Lung Association http://lung.org/lung-health-diseases/lung-disease-lookup/aspergillosis/symptoms-diagnosis
Céline M. O’Gorman, Airborne Aspergillus fumigatus conidia: a risk factor for aspergillosis, Fungal Biology Reviews, Volume 25, Issue 3, 2011, Pages 151-157, https://doi.org/10.1016/j.fbr.2011.07.002.
Reducing Risk for Aspergillosis, US centre for disease control and prevention, https://www.cdc.gov/aspergillosis/prevention/index.html
Preventing Aspergillus Fumigatus: Your Guide to a Fungus-Free Environment, Ion Bar, https://auraionbar.com/preventing-aspergillus-fumigatus/
Fungal Disease Laboratories, US centre for disease control and prevention, https://www.cdc.gov/fungal/hcp/laboratories/index.html
Core Elements of Antibiotic Stewardship, US centre for disease control and prevention, https://www.cdc.gov/antibiotic-use/hcp/core-elements/index.html
EPA Finalizes Framework for Interagency Collaboration on Resistance Risks Associated with Antibacterial and Antifungal Pesticides, US Enviornment Protection Agency, https://www.epa.gov/pesticides/epa-finalizes-framework-interagency-collaboration-resistance-risks-associated
